Healthequity Inc (NASDAQ:HQY) shares gapped up prior to trading on Thursday . The stock had previously closed at $57.92, but opened at $63.32. Healthequity shares last traded at $65.20, with a volume of 65,102 shares changing hands.
Several equities research analysts recently issued reports on the company. Deutsche Bank started coverage on Healthequity in a research note on Thursday, September 12th. They issued a “buy” rating and a $74.00 price target for the company. Cantor Fitzgerald reiterated a “buy” rating and set a $95.00 price objective on shares of Healthequity in a research note on Wednesday. Goldman Sachs Group initiated coverage on shares of Healthequity in a research report on Monday, October 7th. They issued a “neutral” rating and a $56.00 target price for the company. Zacks Investment Research raised shares of Healthequity from a “sell” rating to a “buy” rating and set a $62.00 price target for the company in a report on Tuesday, November 5th. Finally, KeyCorp reiterated a “buy” rating and set a $77.00 price target (up previously from $70.00) on shares of Healthequity in a research report on Wednesday. Three investment analysts have rated the stock with a hold rating, eleven have given a buy rating and one has given a strong buy rating to the company’s stock. Healthequity has an average rating of “Buy” and a consensus price target of $77.86.
The stock has a 50-day moving average price of $59.98 and a 200-day moving average price of $64.17. The company has a debt-to-equity ratio of 0.04, a current ratio of 22.98 and a quick ratio of 22.98. The company has a market capitalization of $4.44 billion, a P/E ratio of 68.74, a P/E/G ratio of 2.87 and a beta of 1.47.
In other Healthequity news, CFO Darcy G. Mott sold 4,000 shares of Healthequity stock in a transaction that occurred on Wednesday, November 20th. The stock was sold at an average price of $60.39, for a total value of $241,560.00. Following the completion of the sale, the chief financial officer now directly owns 38,000 shares in the company, valued at $2,294,820. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Insiders have sold 12,000 shares of company stock valued at $715,600 in the last ninety days. 3.70% of the stock is currently owned by insiders.
Several institutional investors have recently added to or reduced their stakes in the stock. Meeder Asset Management Inc. bought a new position in shares of Healthequity in the second quarter valued at approximately $25,000. BerganKDV Wealth Management LLC purchased a new position in Healthequity during the 2nd quarter worth $26,000. FTB Advisors Inc. bought a new stake in shares of Healthequity in the 2nd quarter worth $27,000. Griffin Asset Management Inc. bought a new stake in shares of Healthequity in the 2nd quarter worth $29,000. Finally, Nvwm LLC purchased a new stake in shares of Healthequity in the third quarter valued at about $30,000. Institutional investors own 95.84% of the company’s stock.
Healthequity Company Profile (NASDAQ:HQY)
HealthEquity, Inc provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the United States. The company offers healthcare saving and spending platform, a cloud-based platform for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
Featured Story: Understanding Average Daily Trade Volume
Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.